Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient suppo… Read full Trend Edge analysis →
| Current Price | $21.64 |
|---|---|
| Market Cap | $1.26B |
| Float | 32.7M |
| Shares Outstanding | 58.4M |
| Price/Sales (TTM) | 15.03 |
| vs. Analyst Target | +28.1% to analyst PT |
| Profit Margin | -172.99% |
| Operating Margin (TTM) | -141.60% |
| Revenue (TTM) | $83.7M |
| Dividend Rate | None |
| Analyst Target Price | $27.71 (6 analysts) |
| Year | Revenue | Net Income | Gross Profit | EBITDA |
|---|---|---|---|---|
| 2020 | N/A | -$29.5M | N/A | -$28.8M |
| 2021 | N/A | -$34.1M | N/A | -$32.3M |
| 2023 | $7.6M | -$84.2M | -$10.7M | -$73.7M |
| 2024 | $27.8M | -$94.1M | $362,000 | -$76.3M |
| 2025 | $59.8M | -$114M | $24.2M | -$98.0M |
| Quarter | Revenue | Net Income |
|---|---|---|
| Apr 2025 | $17.2M | -$52.1M |
| Jul 2025 | $19.4M | -$25.8M |
| Oct 2025 | $22.6M | -$32.8M |
| Jan 2026 | $24.6M | -$34.2M |
| Insider Ownership | 5.0% |
|---|---|
| Institutional Ownership | 102.9% |
| Short Float | 10.6% |
| % of All Funds Holding | 1.11% |
| Number of Funds Holding | 91 |
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
| Timeframe | SMA | Value | Trend Context |
|---|---|---|---|
| Weekly | 10-Week SMA | $20.59 | Near-term / short-term trend |
| Weekly | 40-Week SMA | $23.19 | Medium-term trend |
| Weekly | 80-Week SMA | $0.00 | Cyclical trend (business cycle) |
| Weekly | 200-Week SMA | $0.00 | Secular trend (multi-year) |
| Monthly | 10-Month SMA | $23.10 | Near-term monthly trend |
| Monthly | 20-Month SMA | $0.00 | Medium-term monthly trend |
| Monthly | 40-Month SMA | $0.00 | Secular monthly trend |
Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
| Price Level | Type | Volume Ratio | Age |
|---|---|---|---|
| $22.90 | resistance | 1.66x | 1 months ago |
| Timeframe | Avg Return | Median | Win Rate | Best | Worst |
|---|---|---|---|---|---|
| Gap | 1.95% | 0.00% | 40.00% | 8.70% | -3.86% |
| 1 Day | -0.01% | -5.77% | 40.00% | 18.64% | -7.38% |
| 1 Week | 7.57% | 2.14% | 80.00% | 35.54% | -2.65% |
| 2 Weeks | 7.95% | 2.33% | 80.00% | 32.23% | -5.16% |
| 1 Month | 7.17% | 3.29% | 60.00% | 24.84% | -1.47% |
Next earnings: June 5, 2026 (10 days away)
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
Institutional holder breakdown coming soon.
Total institutional ownership: 102.9%
Total insider ownership: 5.0%
Founder-led management: Brian Webster (Founder, President, CEO & Director), Phillip D. Foshee (Senior Vice President of Research & Development)
| Total Filings | 11 |
|---|---|
| Net Value | -$1.8M |
| Net Shares Change | -29,091 |
| % of Float | -0.1% |
| C-Suite Filings | 9 |
| Clusters Detected | 1 |
| Name | Title | Net Value | Filings | Activity |
|---|---|---|---|---|
| Webster Brian Daniel | President and Chief Executive Officer | -$1.6M | 5 | N/A |
| COHEN RAYMOND W | +$488,800 | 2 | 2 buy | |
| Ford Alfred J Jr | Chief Commercial Officer | +$340,000 | 1 | 1 buy |
| Umberger Traci S | General Counsel and Chief Administrative Officer | -$50,700.9 | 2 | 1 buy |
| Period | Filings | Insiders | Net Value | Seniority |
|---|---|---|---|---|
| 2025-09-08 – 2025-09-15 | 3 | 3 | +$858,500 | 2 C-suite |
| Date | Insider | Title | Net Value | Price After |
|---|---|---|---|---|
| 2026-03-30 | COHEN RAYMOND W | +$199,800 | Transaction at $19.98, now +8.3% | |
| 2025-09-15 | Umberger Traci S | General Counsel and Chief Administrative Officer | +$229,500 | Transaction at $17.00, now +27.3% |
| 2025-09-15 | Ford Alfred J Jr | Chief Commercial Officer | +$340,000 | Transaction at $17.00, now +27.3% |
| 2025-09-08 | COHEN RAYMOND W | +$289,000 | Transaction at $17.00, now +27.3% | |
| 2026-05-18 | Webster Brian Daniel | President and Chief Executive Officer | -$314,329.5 | Transaction at $20.96, now +3.3% |
| 2026-04-16 | Webster Brian Daniel | President and Chief Executive Officer | -$300,670.5 | Transaction at $20.04, now +8.0% |
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Kestra Medical Technologies, Ltd. Common Stock (KMTS) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.
Get the full AI Consult analysis for KMTS on Trend Edge →